These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 29293402)
21. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion. Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494 [TBL] [Abstract][Full Text] [Related]
22. Downregulation of the long non-coding RNA TUG1 is associated with cell proliferation, migration, and invasion in breast cancer. Fan S; Yang Z; Ke Z; Huang K; Liu N; Fang X; Wang K Biomed Pharmacother; 2017 Nov; 95():1636-1643. PubMed ID: 28950664 [TBL] [Abstract][Full Text] [Related]
23. LncRNA LINP1 regulates acute myeloid leukemia progression via HNF4α/AMPK/WNT5A signaling pathway. Shi J; Dai R; Chen Y; Guo H; Han Y; Zhang Y Hematol Oncol; 2019 Oct; 37(4):474-482. PubMed ID: 31325181 [TBL] [Abstract][Full Text] [Related]
24. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation. Wang H; Fang L; Jiang J; Kuang Y; Wang B; Shang X; Han P; Li Y; Liu M; Zhang Z; Li P Cell Death Dis; 2018 Oct; 9(11):1103. PubMed ID: 30375398 [TBL] [Abstract][Full Text] [Related]
25. LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK. Si X; Zang R; Zhang E; Liu Y; Shi X; Zhang E; Shao L; Li A; Yang N; Han X; Pan B; Zhang Z; Sun L; Sun Y Oncotarget; 2016 Dec; 7(49):81452-81462. PubMed ID: 27845892 [TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA H19 regulates proliferation and doxorubicin resistance in MCF-7 cells by targeting PARP1. Wang Y; Zhou P; Li P; Yang F; Gao XQ Bioengineered; 2020 Dec; 11(1):536-546. PubMed ID: 32345117 [TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA LINP1 regulates repair of DNA double-strand breaks in triple-negative breast cancer. Zhang Y; He Q; Hu Z; Feng Y; Fan L; Tang Z; Yuan J; Shan W; Li C; Hu X; Tanyi JL; Fan Y; Huang Q; Montone K; Dang CV; Zhang L Nat Struct Mol Biol; 2016 Jun; 23(6):522-30. PubMed ID: 27111890 [TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling. Wu H; Zou Q; He H; Liang Y; Lei M; Zhou Q; Fan D; Shen L Cancer Med; 2019 May; 8(5):2484-2495. PubMed ID: 30938104 [TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition. Song R; Zhang J; Huang J; Hai T Cancer Biomark; 2018; 22(3):565-573. PubMed ID: 29843220 [TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells. Chen J; Zhang K; Song H; Wang R; Chu X; Chen L Oncotarget; 2016 Sep; 7(38):62474-62489. PubMed ID: 27566568 [TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA GBCDRlnc1 induces chemoresistance of gallbladder cancer cells by activating autophagy. Cai Q; Wang S; Jin L; Weng M; Zhou D; Wang J; Tang Z; Quan Z Mol Cancer; 2019 Apr; 18(1):82. PubMed ID: 30953511 [TBL] [Abstract][Full Text] [Related]
32. ANRIL promotes chemoresistance via disturbing expression of ABCC1 by regulating the expression of Let-7a in colorectal cancer. Zhang Z; Feng L; Liu P; Duan W Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30279206 [TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2. Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262 [TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness. Shin VY; Chen J; Cheuk IW; Siu MT; Ho CW; Wang X; Jin H; Kwong A Cell Death Dis; 2019 Mar; 10(4):270. PubMed ID: 30894512 [TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells. Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678 [TBL] [Abstract][Full Text] [Related]
36. Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer. Li W; Zhai L; Wang H; Liu C; Zhang J; Chen W; Wei Q Oncotarget; 2016 May; 7(19):27778-86. PubMed ID: 27034004 [TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA RP11-70C1.3 confers chemoresistance of breast cancer cells through miR-6736-3p/NRP-1 axis. Zhang L; Zheng X; Shen A; Hua D; Zhu P; Li C; Han Z Bosn J Basic Med Sci; 2022 Feb; 22(1):87-99. PubMed ID: 34374639 [TBL] [Abstract][Full Text] [Related]
38. Silence of long noncoding RNA UCA1 inhibits malignant proliferation and chemotherapy resistance to adriamycin in gastric cancer. Shang C; Guo Y; Zhang J; Huang B Cancer Chemother Pharmacol; 2016 May; 77(5):1061-7. PubMed ID: 27056384 [TBL] [Abstract][Full Text] [Related]
39. SNHG6 is upregulated in primary breast cancers and promotes cell cycle progression in breast cancer-derived cell lines. Jafari-Oliayi A; Asadi MH Cell Oncol (Dordr); 2019 Apr; 42(2):211-221. PubMed ID: 30826970 [TBL] [Abstract][Full Text] [Related]
40. Research Progress on Long Non-coding RNAs and Drug Resistance of Breast Cancer. Zhang X; Yang H Clin Breast Cancer; 2020 Aug; 20(4):275-282. PubMed ID: 32414649 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]